Literature DB >> 7400417

The fascia in systemic scleroderma.

M Vázquez Botet, J L Sánchez.   

Abstract

Diffuse fasciitis (DF) shares clinical and pathologic features with systemic (SS) and localized scleroderma. The distinct pathologic feature in DF is involvement of the deep fascia, but it is not known if these changes consistently occur in SS. In this study, ten patients with SS underwent deep biopsies for evaluation of the fascia. All cases showed typical dermal histologic findings of scleroderma, and five cases showed thickening and fibrosis of the fascia. This study provides evidence that fascial involvement is not distinctive of DF but may occur in SS. It appears that thickening of the fascia is another morphologic feature shared between DF and SS.

Entities:  

Mesh:

Year:  1980        PMID: 7400417     DOI: 10.1016/s0190-9622(80)80222-2

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

1.  MR findings in patients with disabling musculocutaneous chronic graft-versus-host disease.

Authors:  M Horger; A Boss; W Bethge; C Faul; G Fierlbeck; A Bornemann; C D Claussen; W Vogel
Journal:  Skeletal Radiol       Date:  2008-07-12       Impact factor: 2.199

2.  Eosinophilic fasciitis in association with chronic vasculitic-like leg ulcerations.

Authors:  A L Wong; N Anderson-Wilms; S E Mortensen; K K Colburn
Journal:  Clin Rheumatol       Date:  1993-03       Impact factor: 2.980

3.  Two cases of neurological manifestations in eosinophilia: variations of one disease?

Authors:  S Ostrowitzki; S Zierz
Journal:  Clin Investig       Date:  1994-12

4.  [Eosinophilic fasciitis (Shulman syndrome)].

Authors:  P Herzer; H S Füessl; M Meurer; M Schattenkirchner
Journal:  Klin Wochenschr       Date:  1982-11-02

5.  Reflections on the theory of "silver bullet" octreotide tracers: implications for ligand-receptor interactions in the age of peptides, heterodimers, receptor mosaics, truncated receptors, and multifractal analysis.

Authors:  Roy Moncayo
Journal:  EJNMMI Res       Date:  2011-07-26       Impact factor: 3.138

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.